The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration
- 1 November 2000
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 130 (5) , 658-663
- https://doi.org/10.1016/s0002-9394(00)00643-7
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degenerationOphthalmology, 1999
- Genetic Association of Apolipoprotein E with Age-Related Macular DegenerationAmerican Journal of Human Genetics, 1998
- Laser treatment in eyes with large drusen: Short-term effects seen in a pilot randomized clinical trialOphthalmology, 1998
- Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular DegenerationScience, 1997
- Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophyNature Genetics, 1994
- Racial Differences in the Cause-Specific Prevalence of Blindness in East BaltimoreNew England Journal of Medicine, 1991
- George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Oral Zinc in Macular DegenerationArchives of Ophthalmology (1950), 1988
- The Lipid Composition of Aging Sclera and CorneaOphthalmologica, 1975
- Senile Choroidal Vascular Patterns and DrusenArchives of Ophthalmology (1950), 1963